Neuroendocrine Differentiation in Prostate Cancer: From Lab to Bedside
Authors:
- Luca CindoloLCLuca Cindolo
- Monica CantileMonica Cantile
- Francis VacherotFVFrancis Vacherot
- Stéphane TerryStéphane Terry
- Alexandre de la TailleATAlexandre de la Taille
- 1 November 2007
- journal article
- review article
- Published by S. Karger AG in Urologia Internationalis
- Vol. 79 (4) , 287-296
Abstract
Objectives: To discuss the current knowledge on induction, production, sustenance and promotion of neuroendocrine differentiation in human prostate cancer. Methods: Review of the literature using PubMed search and scientific journal publications. Results: Morphological evidence explains some functional relationship between neuroendocrine and neoplastic surrounding cells. Transdifferentiation phenomenon and new biochemical pathways could be included in the development of androgen independence and prostate cancer progression. Conclusion: Multiple evidence seems to confirm that a synergistic functional network between epithelial PSA secretory cells and neuroendocrine intraprostatic system is the main trigger for the induction and sustenance of neuroendocrine differentiation. The development of new antineoplastic molecules should consider the multiple interference of the intercellular network.Keywords
This publication has 76 references indexed in Scilit:
- Clinical implications of neuroendocrine differentiation in prostate cancerProstate Cancer and Prostatic Diseases, 2006
- Linkage between cellular communications, energy utilization, and proliferation in metastatic neuroendocrine cancersProceedings of the National Academy of Sciences, 2006
- Protocadherin-PC promotes androgen-independent prostate cancer cell growthThe Prostate, 2006
- Brn-3a neuronal transcription factor functional expression in human prostate cancerProstate Cancer and Prostatic Diseases, 2005
- cAMP induced modifications of HOX D gene expression in prostate cells allow the identification of a chromosomal area involved in vivo with neuroendocrine differentiation of human advanced prostate cancersJournal of Cellular Physiology, 2005
- A Human- and Male-Specific Protocadherin that Acts through the Wnt Signaling Pathway to Induce Neuroendocrine Transdifferentiation of Prostate Cancer CellsCancer Research, 2005
- Molecular analysis integrating different pathways associated with androgen-independent progression in LuCaP 23.1 xenograftOncogene, 2004
- Interleukin-6- and Cyclic AMP-Mediated Signaling Potentiates Neuroendocrine Differentiation of LNCaP Prostate Tumor CellsMolecular and Cellular Biology, 2001
- Clinical and Experimental Progression of a New Model of Human Prostate Cancer and Therapeutic ApproachThe American Journal of Pathology, 2001
- Prognostic value of neuroendocrine serum markers and PSA in irradiated patients with pN0 localized prostate cancerThe Prostate, 2001